NRN1 as a therapeutic target for Alzheimer's disease
Abstract INTRODUCTION Neuritin‐1 (NRN1) was identified as a synaptic protein associated with cognitive resilience to Alzheimer's disease (AD). METHODS Target risk score and cell type expression profiles were generated for NRN1 using methods developed by the Emory‐Sage‐SGC‐JAX Target Enablement to Accelerate Therapy Development for Alzheimer's Disease ...
Derian A. Pugh +6 more
wiley +1 more source
Effects of Neurotrophin-3 on Intrinsic Neuronal Properties at a Central Auditory Structure. [PDF]
Takahashi M, Sanchez JT.
europepmc +1 more source
Abstract INTRODUCTION While current blood‐based biomarkers for Alzheimer's disease (AD) are effective for determining amyloid beta (Aβ) pathology positivity/negativity, they are insufficient for quantifying Aβ plaque deposition. METHODS We profiled 325 plasma proteins in a Hong Kong Chinese cohort using the Nucleic Acid Linked Immuno‑Sandwich Assay ...
Wenyue Zheng +22 more
wiley +1 more source
Spinal cord stimulation induces Neurotrophin-3 to improve diabetic foot disease. [PDF]
Liu Y +5 more
europepmc +1 more source
Serum Brain-Derived Neurotrophic Factor, Glial-Derived Neurotrophic Factor, Nerve Growth Factor and Neurotrophin-3 Levels in Preschool Children with Language Disorder. [PDF]
Bilgiç A +3 more
europepmc +1 more source
Abstract Hibernation induces significant molecular and cellular adaptations in the retina to maintain function under reduced metabolic conditions. This study aimed to investigate the expression of neuronal, synaptic, and glial markers in the retina of Spermophilus xanthoprymnus during pre‐hibernation and hibernation periods using immunohistochemical ...
Mehmet Özbek +5 more
wiley +1 more source
Safe subdural administration and retention of a neurotrophin-3-delivering hydrogel in a rat model of spinal cord injury. [PDF]
Meissner S +7 more
europepmc +1 more source
AAV Assembled Capsids Are Produced in Cells Blocked From Cell Cycle Progression
ABSTRACT Adeno‐associated virus (AAV) is a promising delivery system for gene therapy. However, current manufacturing of AAV suffers from very low yields compared to other biotherapeutics. The AAV dose per patient ranges between 1011and 1015 viral genomes (vg), requiring an average of 10 to 30 L production/dose.
Alaka Mullick +8 more
wiley +1 more source
Modifications in the C-terminal tail of TrkC significantly alter neurotrophin-3-promoted outgrowth of neurite-like processes from PC12 cells. [PDF]
Krawczyk P, Klopotowska D, Matuszyk J.
europepmc +1 more source
The Impact of Moderate to High Intensity Physical Activity on Sleep Health in Cancer Survivors
ABSTRACT Background Sleep disturbances are common among cancer survivors and negatively impact quality of life. Regular moderate‐ to high‐intensity physical activity may provide a cost‐effective, low‐risk alternative strategy to improve sleep. Methods Data collected as part of two distinct studies, the Detroit Research On Cancer Survivors (ROCS) cohort
Grace E. Markey +10 more
wiley +1 more source

